Working... Menu
Trial record 59 of 889 for:    LENALIDOMIDE

Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma (REVRI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01956695
Recruitment Status : Completed
First Posted : October 8, 2013
Last Update Posted : July 10, 2019
Centre Hospitalier Universitaire, Amiens
Institut Bergonié
University Hospital, Clermont-Ferrand
University Hospital, Lille
Central Hospital, Nancy, France
Groupe Hospitalier Pitie-Salpetriere
Centre Henri Becquerel
University Hospital, Tours
Centre Leon Berard
University Hospital, Grenoble
Information provided by (Responsible Party):
Institut Curie